Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Analyst Ratings

• Total Analysts: n/a
• Consensus Rating: n/a
• Price Target: n/a
• Upside: n/a

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $3 → $7	Buy	Maintains	$3 → $7	+786.08%	Jan 17, 2023
Yasmeen Rahimi Piper Sandler	Piper Sandler	Hold → Buy Upgrades $2 → $3	Hold → Buy	Upgrades	$2 → $3	+279.75%	Jan 6, 2023
Michael Yee Jefferies	Jefferies	Hold → Strong Buy Upgrades $2.5 → $3	Hold → Strong Buy	Upgrades	$2.5 → $3	+279.75%	Jan 6, 2023
Roanna Ruiz SVB Leerink	SVB Leerink	Hold Maintains $3 → $2	Hold	Maintains	$3 → $2	+153.16%	Nov 3, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy → Hold Downgrades $7 → $3	Buy → Hold	Downgrades	$7 → $3	+279.75%	May 5, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy Maintains $11 → $7	Buy	Maintains	$11 → $7	+786.08%	Mar 23, 2022
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy → Hold Downgrades $15 → $4	Buy → Hold	Downgrades	$15 → $4	+406.33%	Mar 23, 2022
Yasmeen Rahimi Piper Sandler	Piper Sandler	Buy Maintains $47 → $15	Buy	Maintains	$47 → $15	+1,798.73%	Mar 11, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy Maintains $10 → $11	Buy	Maintains	$10 → $11	+1,292.41%	Mar 11, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy Maintains $15 → $10	Buy	Maintains	$15 → $10	+1,165.82%	Feb 16, 2022
Eric Joseph JP Morgan	JP Morgan	Buy → Hold Downgrades $30 → $12	Buy → Hold	Downgrades	$30 → $12	+1,418.99%	Jan 7, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy Maintains $29 → $15	Buy	Maintains	$29 → $15	+1,798.73%	Jan 7, 2022
Roanna Ruiz SVB Leerink	SVB Leerink	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Sep 9, 2021
Tyler Van Buren Piper Sandler	Piper Sandler	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Nov 10, 2020